Sector: Consumer Non-Cyclicals | Industry: Food Retail & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 250 E Parkcenter Blvd BOISE ID 83706-3940 |
Tel: | N/A |
Website: | https://www.albertsonscompanies.com |
IR: | See website |
Key People | ||
James L. Donald Co-Chairman of the Board | Omer Gajial Executive Vice President - Health, Chief Digital Officer | Chan W. Galbato Co-Chairman of the Board |
Sharon L. Mccollam President, Chief Financial Officer | Vivekanan Sankaran Chief Executive Officer, Director | Brian Kevin Turner Vice Chairman of the Board |
Susan Morris Chief Operations Officer, Executive Vice President | Michael Theilmann Chief Human Resource Officer, Executive Vice President | Anuj Dhanda Executive Vice President, Chief Technology and Transformation Officer | Thomas M. Moriarty Executive Vice President, General Counsel |
Business Overview |
Albertsons Companies, Inc. is a food and drug retailer in the United States. The Company is engaged in the operation of food and drug retail stores that offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through digital channels. The Company operates approximately 2,271 stores across 34 states and the District of Columbia under 24 banners including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, Market Street, Haggen, Kings Food Markets and Balducci's Food Lovers Market. The Company operates approximately 1,722 pharmacies, 1,328 in-store branded coffee shops, 401 associated fuel centers, 22 dedicated distribution centers, 19 manufacturing facilities and various digital platforms. Its own brands include Signature SELECT, Open Nature, Signature Cafe, Lucerne, Waterfront BISTRO, Primo Taglio, Signature Care, Signature Reserve and Value Corner. |
Financial Overview |
For the fiscal year ended 24 February 2024, Albertsons Companies Inc revenues increased 2% to $79.24B. Net income applicable to common stockholders increased 7% to $1.3B. Revenues reflect Pharmacy segment increase of 22% to $8.24B, Retail Sales -Pharmacy increase of 22% to $8.24B. Net income benefited from Depreciation/Amortization in SGA decrease of 2% to $1.61B (expense). Dividend per share remained flat at $0.48. |
Employees: | 108,300 as of Feb 24, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $19,562M as of Feb 24, 2024 |
Annual revenue (TTM): | $79,238M as of Feb 24, 2024 |
EBITDA (TTM): | $4,110M as of Feb 24, 2024 |
Net annual income (TTM): | $1,295M as of Feb 24, 2024 |
Free cash flow (TTM): | $351.20M as of Feb 24, 2024 |
Net Debt Last Fiscal Year: | $7,857M as of Feb 24, 2024 |
Shares outstanding: | 577,407,663 as of Apr 18, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |